Aspen Aerogels, Inc. (NYSE:ASPN – Get Free Report) major shareholder Wood River Capital, Llc sold 12,280,426 shares of the business’s stock in a transaction on Wednesday, September 23rd. The stock was sold at an average price of $4.73, for a total transaction of $58,086,414.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Aspen Aerogels Price Performance
Aspen Aerogels stock traded down $0.39 during midday trading on Thursday, reaching $5.29. The company had a trading volume of 2,364,746 shares, compared to its average volume of 683,511. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24. Aspen Aerogels, Inc. has a 12-month low of $2.30 and a 12-month high of $9.35. The company has a market capitalization of $439.18 million, a P/E ratio of -3.46 and a beta of 2.97. The firm’s fifty day simple moving average is $5.19 and its 200-day simple moving average is $4.87.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last announced its earnings results on Thursday, August 6th. The construction company reported ($0.22) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.01. The business had revenue of $49.85 million during the quarter, compared to analysts’ expectations of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%.Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. As a group, equities analysts anticipate that Aspen Aerogels, Inc. will post -0.69 EPS for the current year.
Institutional Trading of Aspen Aerogels
Wall Street Analyst Weigh In
ASPN has been the subject of a number of research reports. Wall Street Zen lowered shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Barclays raised their price target on shares of Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 11th. B. Riley Financial reaffirmed a “buy” rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Roth Capital reiterated a “buy” rating and issued a $7.75 price objective on shares of Aspen Aerogels in a report on Friday, August 7th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday. Four analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Aspen Aerogels has an average rating of “Hold” and a consensus target price of $5.94.
Check Out Our Latest Report on Aspen Aerogels
About Aspen Aerogels
Aspen Aerogels, Inc is a technology company that develops, manufactures and sells advanced aerogel-based materials. Aerogels are highly porous materials designed to provide thermal insulation, fire protection and other performance benefits in applications where conventional insulation may be less effective or require more space.
The company serves the energy, industrial and automotive markets. Its products include thermal barriers for electric vehicle batteries, insulation materials for industrial and energy infrastructure, and specialty aerogel products used in applications involving heat management, fire mitigation and cryogenic or high-temperature environments.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
